Corbion today announced it will strengthen its Executive Committee with the appointment of two new members, to help drive its Advance 2025 strategy that will be presented today during a Capital Markets Day in Amsterdam. Marco Bootz, currently Senior Vice President Sales EMEA, has been named President Lactic Acid & Specialties, while Ruud Peerbooms, now Senior Vice President Food, will be President Algae Ingredients. The appointments will be effective as of 1 April 2020.

Since joining Corbion in 2007 in Brazil as Commercial Director for Latin America, Mr. Bootz moved on to lead the Global Chemical and Pharma business, and then became SVP Biochemicals. Mr. Peerbooms joined Corbion in 2014 as SVP Food, and prior to that worked in business development and sales at Kerry Group and Unilever.

CEO Olivier Rigaud commented: "I am really pleased to welcome Marco and Ruud to the ExCo team; they bring in-depth knowledge of the global Corbion business as well as the leadership qualities to successfully execute our growth agenda in the coming years."
Six Executive Committee members will continue: next to CEO Olivier Rigaud and CFO Eddy van Rhede van der Kloot these are: Jacqueline van Lemmen (Chief Operations Officer), Johan van der Hel (Chief Human Resources Officer), Andy Muller (President Sustainable Food Solutions) and Marcel Wubbolts (Chief Science & Sustainability Officer).

AND
During its Capital Markets Day for analysts and investors in Amsterdam today, Corbion management will present its strategy for the period 2020-2025: Advance 2025. As our portfolio is uniquely aligned with global market trends, the strategy builds on Corbion’s fundamentals and strengths by bringing further focus to the business portfolio. This will be achieved by increased investments in key growth areas like natural food preservation and lactic acid, while at the same time reducing the breadth of our business portfolio. With our purpose ‘Championing preservation in all its forms: preserving food and food production, health, and the planet’, sustainability will become even more important in all our decision-making processes.

Olivier Rigaud, CEO of Corbion, comments: “In the past years, Corbion has built a solid foundation. This strategy builds on those foundations in an evolutionary way.

In food, Corbion has developed increasingly from an ingredients business into a solutions business. We plan to expand on this solutions model with natural food preservation and functional systems as our core capabilities, enabling us to accelerate growth in close adjacencies.

In our lactic acid business, we aim to capitalize on our market and technology leadership. To further strengthen this leadership position in an attractive growth market, we have decided to build a new lactic acid plant at the existing Corbion site in Rayong Province in Thailand. As PLA is developing better than expected, the urgency behind expanding our lactic acid production capacity has only increased.

In our Incubator, where we develop early stage initiatives, we plan to bring omega-3 DHA to profitability in 2022, while we stay committed to investing in initiatives with a longer time horizon.

Some 17% of our total sales will be classified as non-core. For several non-core activities such as our frozen dough business and our FDCA initiative, we will look for exit scenarios. For others, such as our emulsifiers business, we will manage for value. By thus bringing more focus to the portfolio we believe we can accelerate growth of the company.

At Corbion, sustainability is at the heart of what we do. We are very well positioned to benefit from the worldwide drive for more sustainable products and solutions. We have aligned our Advance 2025 strategy to the United Nations Sustainable Developments Goals (SDGs) with SDG 2 Zero hunger, SDG 3 Good health and well-being, and SDG 12 Responsible consumption and production being the goals where Corbion can have the most impact.”

Our business and reporting structure will have three business units from now on:

Sustainable Food Solutions: Supported by an industry that is rapidly moving towards clean label/natural food solutions we will leverage our strengths in preservation. Sustainable Food Solutions will consist of three segments: Preservation, Functional systems, and Single Ingredients. In the Preservation segment, we intend to expand our (natural) preservation solutions from meat into other markets. In the Functional systems segment, we will focus on natural/clean label solutions in bakery and other markets. Both segments could be supported by bolt-on M&A. Emulsifiers will have a declining strategic fit going forward and will be managed for value. Other non-core activities such as co-packing blending, and frozen dough will be exited.

Lactic Acid & Specialties: We will capitalize on our global product leadership in lactic acid and lactic acid derivatives. Corbion leads the lactic acid market in technology, production capacity, geographic coverage and breadth of portfolio. Lactic Acid & Specialties will consist of 5 segments: Lactic acid (including for PLA), lactates, lactate esters, biopolymers and other. Lactic acid serving the PLA market is already driving substantial investments in our lactic acid infrastructure. By 2023 we expect to open a new 125kTpa lactic acid plant in Thailand, operating at the highest sustainability standards and lowest costs. The additional lactic acid capacity also shows our commitment to continue to support future growth of the Total Corbion PLA joint venture.

Incubator: We will develop larger, early-stage investments in the Incubator. Our three main product categories are: Algae-based Omega-3, starting with fish feed applications, algae proteins (in cooperation with Nestlé), and our new co-polymer platform. This platform is a lactic acid-based controlled-release co-polymer technology, expanding on our (medical) polymer expertise.

We will continue to invest >4% of sales in R&D to support our growth. In the coming years R&D resources will be intensified in Sustainable Food Solutions and Lactic Acid & Specialties. Next to the Omega-3 initiative, annual EBITDA investments for other initiatives in the Incubator are expected to be in the range of 0.5% to 1.5% of core net sales.

Financial guidance 2020-2025

Financial targets 2020-2025 (for core activities)

Annual organic net sales growth 4-7%
EBITDA margin >17% from 2025 onwards (2019: 15.1%)
Underlying ambitions

Organic net sales growth Sustainable Food Solutions ~3%
Organic net sales growth Lactic Acid & Specialties ~7%
Algae-based Omega-3 DHA business EBITDA break-even in 2022
EBITDA investments of other Incubator initiatives: up to ~0.5-1.5% of Corbion core sales
Capex: Recurring capex of € 60-70 million per annum. Additional average capex in 2020-2022: € 55 million p.a. for new lactic acid plant in Thailand
Net Debt/EBITDA: Target is 2.0x over the cycle. Estimated to peak at ~2.5x during construction period of new lactic acid plant (2020-2023)
Dividend per share: progressive dividend @ 0.56/share (to be annually reviewed; subject to market outlook, financial position, additional large investments, M&A, and divestments)
Financial guidance 2020 (for core activities)

Organic net sales growth in 4-7% range
EBITDA margin is expected to be stable vs FY19 at ~15%

AND for ours English readers
Corbion reported net sales of € 976.4 million in 2019. Organic net sales growth was 2.5% for
the year. Adjusted EBITDA in 2019 increased organically by 7.8% to € 145.9 million. These results are in line with the earlier management update of 29 January 2020. The company proposes to distribute a regular dividend of € 0.56 per share.

Olivier Rigaud, CEO, commented: “Looking back at 2019, I am pleased with the strong fourth quarter as we saw a further acceleration of organic growth. These results are in line with the earlier management update of 29 January 2020. Our FY 2019 results exceeded our management guidance of October 2019 for Ingredient Solutions, while Innovation Platforms performed as expected. Today we are excited to present our Advance 2025 strategy which talks about our vision for the Corbion future including the outlook for 2020.”

Key financial highlights FY 2019:

Net sales organic growth was 2.5%; volume growth was 3.4%
Adjusted EBITDA was € 145.9 million (FY 2018: € 131.6 million), an organic increase of 7.8% (including 6.1% positive effect from IFRS 16 implementation)
Adjusted EBITDA margin was 14.9% (FY 2018: 14.7%)
Adjustments at EBITDA level of € +18.4 million
Impairment of € 41.4 million related to our Algae business
Operating result was € 61.3 million (FY 2018: 87.9 million)
Free cash flow was € 9.6 million (FY 2018: € 11.9 million); the decline is mostly due to the acquisition of Granotec do Brazil (25 April 2019)
Net debt/EBITDA at year-end was 2.0x (year-end 2018: 1.6x)

see More on
https://ml-eu.globenewswire.com/Resource/Download/99495353-0f50-40d2-a06e-92e6a63a71cb